A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 687 participants.
Also called NCT03626688
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 687 participants
- Sponsor
- Registry
-
NCT03626688
-
- Other papers using this trial's data
- Ralinepag for the treatment of pulmonary arterial hypertension (ADVANCE OUTCOMES): a randomised, double-blind, placebo-controlled phase 3 study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Croatia, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Mexico, Netherlands, Poland, Portugal, Romania, Serbia, Singapore, South Korea, Spain, Sweden, Taiwan, Türkiye, Ukraine, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03626688. Randomized; quadruple masking; primary purpose treatment. Start 2019-01-24 (actual); primary completion 2025-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
- Condition
- PAH
- Condition
- Pulmonary Hypertension
- Condition
- Pulmonary Arterial Hypertension
- Condition
- Hypertension
- Condition
- Connective Tissue Diseases
- Condition
- Familial Primary Pulmonary Hypertension
- Condition
- Vascular Diseases
- Condition
- Cardiovascular Diseases
- Condition
- Hypertension, Pulmonary
- Condition
- Lung Diseases
- Condition
- Respiratory Tract Disease
- Intervention (Drug)
- Ralinepag
- Intervention (Drug)
- Placebo
- Lead sponsor
- United Therapeutics
Record details
- Record id
cardio:ct-nct03626688- Content hash
ba2c727294fe8b81976b0e7c76502b1fab440b9fe4ff2b35c41466cc10514746